华纳药厂：全资子公司通过药品GMP符合性检查

Core Viewpoint - Warner Pharmaceuticals (688799) announced that its wholly-owned subsidiary, Chiral Pharmaceuticals, has received a GMP compliance inspection notice from the Hunan Provincial Drug Administration, allowing the company to officially produce and sell two raw materials: ipratropium bromide and dimethicone [1] Group 1 - The company has successfully passed the GMP compliance inspection for its raw materials [1] - The approval signifies a key milestone for Chiral Pharmaceuticals in expanding its production capabilities [1] - The products approved for production are ipratropium bromide and dimethicone, which are essential raw materials in the pharmaceutical industry [1]